Making sense of genetic associations with childhood leukaemia risk

Childhood Cancer 2016: Conference review

Antibody-based and bispecific T-cell dependent therapies

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Immune strategies for treating neuroblastoma

The timeline of adjuvant and neoadjuvant therapy for melanoma

Effects of ultraviolet light on underlying genes behind at-risk phenotypes

Targeted therapies in melanoma

Causes, symptoms, and prevention of skin cancer

Developments in checkpoint immunotherapy

Targetted medicine to reduce melanoma mutational burden

Checkpoint inhibitor therapy for treating melanoma